Zobrazeno 1 - 10 of 48 pro vyhledávání: '"Luis A. Lemus"'
1
Akademický článek
Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury
Autor: Annayya R. Aroor, Nitin A. Das, Andrea J. Carpenter, Javad Habibi, Guanghong Jia, Francisco I. Ramirez-Perez, Luis Martinez-Lemus, Camila M. Manrique-Acevedo, Melvin R. Hayden, Cornel Duta, Ravi Nistala, Eric Mayoux, Jaume Padilla, Bysani Chandrasekar, Vincent G. DeMarco
Publikováno v: Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-14 (2018)
Abstract Background Arterial stiffness is emerging as an independent risk factor for the development of chronic kidney disease. The sodium glucose co-transporter 2 (SGLT2) inhibitors, which lower serum glucose by inhibiting SGLT2-mediated glucose rea
Externí odkaz: https://doaj.org/article/762775bbe4d347228d8b8580356663b2
Zobrazit plný text záznamu
5
Neuraminidase-1 inhibition reduces arterial stiffness and improves endothelial function in diabetic mice
Autor: Edgar Betancourt-Cortes, Christopher Foote, Francisco Ramirez-Perez, Thomas Jurrisen, Gavin Power, Mariana Morales-Quiñones, Yoskaly Lazo-Fernandez, Marc Augenreich, Camila Manrique-Acevedo, Jaume Padilla, Luis Martinez-Lemus
Publikováno v: Physiology. 38
Plasma neuraminidase (Neu) activity has been shown to be increased in type 2 diabetes (T2D). The net result of neuraminidase activity is cleavage of sialic acid moieties from structures such as the glycoproteins and proteoglycans found in the glycoca
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e78a53f9d979b9cd8d78bf8793ae42cb
https://doi.org/10.1152/physiol.2023.38.s1.5796078
Zobrazit plný text záznamu
6
LIM kinase inhibition reduces endothelial cell cortical stiffness in diabetic arteries
Autor: Gavin Power, Juan Gonzalez-Vallejo, Francisco Ramirez-Perez, Olubodun Lateef, Camila Manrique-Acevedo, Luis Martinez-Lemus, Jaume Padilla
Publikováno v: Physiology. 38
Type 2 diabetes is associated with endothelial stiffening, which precedes the development of increased arterial stiffness. The role of endothelial cell stiffening in the pathogenesis of vascular disease is increasingly recognized. Indeed, evidence ex
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bc5a0638f4fe249e30c7f21b2ba1552b
https://doi.org/10.1152/physiol.2023.38.s1.5795981
Zobrazit plný text záznamu
7
Zanamivir infusion improves endothelial function and reduces arterial stiffness in diabetic mice
Autor: Mariana Morales-Quinones, Christopher Foote, Francisco Ramirez-Perez, Thomas Jurrissen, Gavin Power, Edgar Betancourt-Cortes, Yoskaly Lazo-Fernandez, Marc Augenreich, Camila Manrique-Acevedo, Jaume Padilla, Luis Martinez-Lemus
Publikováno v: Physiology. 38
Endothelial dysfunction and arterial stiffening are consistently manifested in type 2 diabetes (T2D) and contribute to the development of cardiovascular disease. Consequently, there is an urgent need to identify novel therapies that improve endotheli
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::af4f7c62ca8579f36c899f4137864266
https://doi.org/10.1152/physiol.2023.38.s1.5795909
Zobrazit plný text záznamu
8
Targeted pharmacological inhibition of neuraminidase-3 ameliorates vascular dysfunction in diabetic mice
Autor: Christopher Foote, Francisco Ramirez-Perez, Thomas Jurrissen, Gavin Power, Mariana Morales-Quinones, Edgar Betancourt-Cortes, Yoskaly Lazo-Fernandez, Marc Augenreich, Camila Manrique-Acevedo, Jaume Padilla, Luis Martinez-Lemus
Publikováno v: Physiology. 38
In type 2 diabetes (T2D), endothelial dysfunction and arterial stiffening play a significant role in the development of cardiovascular disease. A central mediator of vascular dysfunction is degradation of the endothelial glycocalyx, a semipermeable m
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::babebdd23137c7531a22516a3a7ee345
https://doi.org/10.1152/physiol.2023.38.s1.5795825
Zobrazit plný text záznamu
9
Multi-omic analysis of the cardiac cellulome defines a vascular contribution to cardiac diastolic dysfunction in obesity
Autor: Shawn Bender, Malathi Dona, Ian Hsu, Alex Meuth, Scott Brown, Chastidy Bailey, Christian Aragonez, Bysani Chandrasekar, Luis Martinez-Lemus, Vincent DeMarco, Laurel Grisanti, Iris Jaffe, Alex Pinto
Publikováno v: Physiology. 38
Coronary microvascular dysfunction (CMD) is associated with cardiac dysfunction and predictive of cardiac mortality in obesity, especially in females. Emerging evidence suggests development of heart failure with preserved ejection fraction in females
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5bdf07db8f2d35648e5ba8d5a1d57e60
https://doi.org/10.1152/physiol.2023.38.s1.5735246
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje